(DEDI) Dedicare (publ) - Ratings and Ratios
Recruitment, Staffing, Healthcare, Education, Life Science
DEDI EPS (Earnings per Share)
DEDI Revenue
Description: DEDI Dedicare (publ)
Dedicare AB (publ) is a recruitment and staffing company operating in the healthcare, life science, education, and social work industries across several Nordic countries and the UK. The company provides a range of staffing solutions, including recruitment and interim services, to various industries, leveraging its expertise to meet the needs of its clients.
From a business perspective, Dedicares revenue streams are likely driven by the demand for staffing services in its target markets. Key Performance Indicators (KPIs) to watch include revenue growth, gross margin, and sales per employee, which can indicate the companys operational efficiency and ability to scale its business. Additionally, metrics such as client retention rate, candidate satisfaction rate, and time-to-hire can provide insights into the companys service quality and competitiveness.
To evaluate Dedicares financial health, we can examine its profitability ratios, such as the Return on Equity (RoE) of 15.07%, which suggests that the company is generating profits from its shareholders equity. The Price-to-Earnings (P/E) ratio of 10.23 indicates that the stock is trading at a relatively reasonable valuation compared to its earnings. Other relevant KPIs include the companys debt-to-equity ratio, interest coverage ratio, and cash conversion cycle, which can provide a more comprehensive picture of its financial stability and liquidity.
From a growth perspective, Dedicares expansion into new markets and industries, as well as its ability to adapt to changing regulatory environments, will be crucial in driving its long-term success. The companys ability to innovate its services and leverage technology to enhance its operations will also be important in maintaining its competitive edge. Monitoring KPIs such as the percentage of revenue from new services or markets, and the companys investment in research and development, can provide insights into its growth prospects.
DEDI Stock Overview
| Market Cap in USD | 47m |
| Sub-Industry | Human Resource & Employment Services |
| IPO / Inception |
DEDI Stock Ratings
| Growth Rating | -15.7% |
| Fundamental | 63.5% |
| Dividend Rating | 65.6% |
| Return 12m vs S&P 500 | -42.1% |
| Analyst Rating | - |
DEDI Dividends
| Dividend Yield 12m | 5.34% |
| Yield on Cost 5y | 8.44% |
| Annual Growth 5y | 26.98% |
| Payout Consistency | 82.5% |
| Payout Ratio | 63.9% |
DEDI Growth Ratios
| Growth Correlation 3m | 47.1% |
| Growth Correlation 12m | -79.9% |
| Growth Correlation 5y | 22.1% |
| CAGR 5y | 8.98% |
| CAGR/Max DD 5y | 0.13 |
| Sharpe Ratio 12m | -1.96 |
| Alpha | -31.23 |
| Beta | -0.268 |
| Volatility | 35.29% |
| Current Volume | 3.8k |
| Average Volume 20d | 7k |
| Stop Loss | 43.9 (-3.5%) |
| Signal | 0.74 |
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income (37.3m TTM) > 0 and > 6% of Revenue (6% = 93.2m TTM) |
| FCFTA 0.11 (>2.0%) and ΔFCFTA -6.00pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 7.14% (prev 6.07%; Δ 1.07pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.11 (>3.0%) and CFO 64.6m > Net Income 37.3m (YES >=105%, WARN >=100%) |
| Net Debt (-72.7m) to EBITDA (69.7m) ratio: -1.04 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.45 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (9.65m) change vs 12m ago 0.0% (target <= -2.0% for YES) |
| Gross Margin 15.28% (prev 27.47%; Δ -12.19pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 252.5% (prev 280.9%; Δ -28.34pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 450.0 (EBITDA TTM 69.7m / Interest Expense TTM 100.0k) >= 6 (WARN >= 3) |
Altman Z'' 4.33
| (A) 0.20 = (Total Current Assets 359.2m - Total Current Liabilities 248.3m) / Total Assets 568.0m |
| (B) 0.48 = Retained Earnings (Balance) 272.0m / Total Assets 568.0m |
| (C) 0.07 = EBIT TTM 45.0m / Avg Total Assets 615.0m |
| (D) 0.95 = Book Value of Equity 270.7m / Total Liabilities 285.4m |
| Total Rating: 4.33 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 63.53
| 1. Piotroski 4.0pt = -1.0 |
| 2. FCF Yield 16.66% = 5.0 |
| 3. FCF Margin 4.06% = 1.01 |
| 4. Debt/Equity 0.08 = 2.50 |
| 5. Debt/Ebitda 0.32 = 2.42 |
| 6. ROIC - WACC 17.73% = 12.50 |
| 7. RoE 12.88% = 1.07 |
| 8. Rev. Trend -80.41% = -4.02 |
| 9. Rev. CAGR -8.57% = -1.43 |
| 10. EPS Trend -80.94% = -2.02 |
| 11. EPS CAGR -34.41% = -2.50 |
What is the price of DEDI shares?
Over the past week, the price has changed by -4.21%, over one month by +0.22%, over three months by +4.72% and over the past year by -32.31%.
Is Dedicare (publ) a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of DEDI is around 43.64 SEK . This means that DEDI is currently overvalued and has a potential downside of -4.09%.
Is DEDI a buy, sell or hold?
What are the forecasts/targets for the DEDI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 82 | 80.2% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 47.1 | 3.4% |
DEDI Fundamental Data Overview
Market Cap SEK = 450.9m (450.9m SEK * 1.0 SEK.SEK)
CCE Cash And Equivalents = 95.0m SEK (Cash And Short Term Investments, last quarter)
P/E Trailing = 12.1521
P/S = 0.2901
P/B = 1.5887
Beta = 0.944
Revenue TTM = 1.55b SEK
EBIT TTM = 45.0m SEK
EBITDA TTM = 69.7m SEK
Long Term Debt = unknown (0.0)
Short Term Debt = unknown (0.0)
Debt = 22.3m SEK (From: shortLongTermDebtTotal, last quarter)
Net Debt = -72.7m SEK (from netDebt column, last quarter)
Enterprise Value = 378.2m SEK (450.9m + Debt 22.3m - CCE 95.0m)
Interest Coverage Ratio = 450.0 (Ebit TTM 45.0m / Interest Expense TTM 100.0k)
FCF Yield = 16.66% (FCF TTM 63.0m / Enterprise Value 378.2m)
FCF Margin = 4.06% (FCF TTM 63.0m / Revenue TTM 1.55b)
Net Margin = 2.40% (Net Income TTM 37.3m / Revenue TTM 1.55b)
Gross Margin = 15.28% ((Revenue TTM 1.55b - Cost of Revenue TTM 1.32b) / Revenue TTM)
Tobins Q-Ratio = 1.40 (Enterprise Value 378.2m / Book Value Of Equity 270.7m)
Interest Expense / Debt = 0.45% (Interest Expense 100.0k / Debt 22.3m)
Taxrate = 21.09% (from yearly Income Tax Expense: 12.6m / 59.7m)
NOPAT = 35.5m (EBIT 45.0m * (1 - 21.09%))
Current Ratio = 1.45 (Total Current Assets 359.2m / Total Current Liabilities 248.3m)
Debt / Equity = 0.08 (Debt 22.3m / last Quarter total Stockholder Equity 282.6m)
Debt / EBITDA = 0.32 (Net Debt -72.7m / EBITDA 69.7m)
Debt / FCF = 0.35 (Debt 22.3m / FCF TTM 63.0m)
Total Stockholder Equity = 289.7m (last 4 quarters mean)
RoA = 6.57% (Net Income 37.3m, Total Assets 568.0m )
RoE = 12.88% (Net Income TTM 37.3m / Total Stockholder Equity 289.7m)
RoCE = 15.53% (Ebit 45.0m / (Equity 289.7m + L.T.Debt 0.0))
RoIC = 22.54% (NOPAT 35.5m / Invested Capital 157.5m)
WACC = 4.81% (E(450.9m)/V(473.2m) * Re(5.03%)) + (D(22.3m)/V(473.2m) * Rd(0.45%) * (1-Tc(0.21)))
Shares Correlation 5-Years: 66.70 | Cagr: 0.68%
Discount Rate = 5.03% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 78.42% ; FCFE base≈83.1m ; Y1≈83.8m ; Y5≈90.5m
Fair Price DCF = 211.7 (DCF Value 1.60b / Shares Outstanding 7.55m; 5y FCF grow 0.49% → 3.0% )
Revenue Correlation: -80.41 | Revenue CAGR: -8.57%
Rev Growth-of-Growth: -16.13
EPS Correlation: -80.94 | EPS CAGR: -34.41%
EPS Growth-of-Growth: -37.61